Biotech Values

[DewDiligence]

ACHN:

…viral load remained suppressed for at least 7 days after dosing was completed. Isn't it normal for viral loads to quickly rebound in these studies? If so, I presume that this is potentially a good differentiating characteristic for ACH-1625.

The obvious question is: To what extent were viral loads suppressed 7 days after the cessation of dosing (i.e. 12 days into the study)? The mere use of the word suppressed does not tell us much.